Univeristy of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599-7600.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Univeristy of North Carolina at Chapel Hill has participated in 7 clinical trials with 5 currently active.
Therapeutic areas: Drug Induced Liver Injury, Endometrium Cancer, Sentinel Lymph Node.
Sponsors: Duke University, UNC Lineberger Comprehensive Cancer Center, Biogen.
Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Univeristy of North Carolina at Chapel Hill has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Univeristy of North Carolina at Chapel Hill has 7 clinical trials on record, with 5 currently active. Their work covers Drug Induced Liver Injury, Endometrium Cancer, Sentinel Lymph Node.
Univeristy of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.